Cescon, D. W., Rushton, M., LeVasseur, N., Nadler, M. B., Rayson, D., Wilson, B., Taylor, S. K., Pezo, R. C., Awan, A. A. A., Kumar, V., Melvin, J. E., Hilton, J. F., Chia, S. K. L., Bedard, P., Finn, S., Tu, W., Coschi, C., Jamme, P., Aguado-Fraile, E., Seymour, L. K. (2025). IND.241: A Canadian Cancer Trials Group liquid-biopsy informed platform trial to evaluate treatment in CDK4/6-inhibitor resistant ER+/HER2- metastatic breast.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps1121